Multiple Rising Oral Doses of BI 201335 NA for Hepatitis

ID Number 07-0859

Principal Investigator(s)
Douglas Dieterich

Department(s) or Division(s)
Liver Diseases


The study is designed to find out if the new drug is effective, safe, and to determine the level of the drug in the patient's body (pharmacokinetics).

Contact Information
Douglas Dieterich, MD

Recruiting Patients: No